Header Logo

Connection

Laurel Habel to Risk Factors

Back to Details
This is a "connection" page, showing publications Laurel Habel has written about Risk Factors.
Laurel Habel
Connection Strength
1.969
Risk Factors
  1. Examination of fully automated mammographic density measures using LIBRA and breast cancer risk in a cohort of 21,000 non-Hispanic white women. Breast Cancer Res. 2023 08 06; 25(1):92.
    View in: PubMed
    Score: 0.132
  2. Blood pressure lowering medication initiation and fracture risk: a SWAN pharmacoepidemiology study. Arch Osteoporos. 2019 06 28; 14(1):73.
    View in: PubMed
    Score: 0.099
  3. Confounding by alcohol use: benzodiazepines and risk of liver cancer. Br J Clin Pharmacol. 2015 May; 79(5):872-3.
    View in: PubMed
    Score: 0.075
  4. Metformin use and lung cancer risk in patients with diabetes. Cancer Prev Res (Phila). 2015 Feb; 8(2):174-9.
    View in: PubMed
    Score: 0.073
  5. Association between high-sensitivity C-reactive protein (hsCRP) and change in mammographic density over time in the SWAN mammographic density subcohort. Cancer Causes Control. 2015 Mar; 26(3):431-42.
    View in: PubMed
    Score: 0.073
  6. Complications of herpes zoster in cancer patients. Scand J Infect Dis. 2014 Jul; 46(7):528-32.
    View in: PubMed
    Score: 0.070
  7. Risk factors for non-invasive and invasive local recurrence in patients with ductal carcinoma in situ. Breast Cancer Res Treat. 2013 Jun; 139(2):453-60.
    View in: PubMed
    Score: 0.065
  8. HOXB13:IL17BR and molecular grade index and risk of breast cancer death among patients with lymph node-negative invasive disease. Breast Cancer Res. 2013 Mar 14; 15(2):R24.
    View in: PubMed
    Score: 0.064
  9. Metabolic syndrome and mammographic density: the Study of Women's Health Across the Nation. Int J Cancer. 2011 Oct 01; 129(7):1699-707.
    View in: PubMed
    Score: 0.056
  10. Mammographic density and risk of second breast cancer after ductal carcinoma in situ. Cancer Epidemiol Biomarkers Prev. 2010 Oct; 19(10):2488-95.
    View in: PubMed
    Score: 0.054
  11. Active, but not passive cigarette smoking was inversely associated with mammographic density. Cancer Causes Control. 2010 Feb; 21(2):301-11.
    View in: PubMed
    Score: 0.052
  12. Relationship between clinical and pathologic features of ductal carcinoma in situ and patient age: an analysis of 657 patients. Am J Surg Pathol. 2009 Dec; 33(12):1802-8.
    View in: PubMed
    Score: 0.051
  13. Thiazolidinedione therapy is not associated with increased colonic neoplasia risk in patients with diabetes mellitus. Gastroenterology. 2008 Dec; 135(6):1914-23, 1923.e1.
    View in: PubMed
    Score: 0.047
  14. Pharmaceuticals that cause mammary gland tumors in animals: findings in women. Breast Cancer Res Treat. 2009 Jul; 116(1):187-94.
    View in: PubMed
    Score: 0.047
  15. Erratum: Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361 859 recipients. Pharmacoepidemiol Drug Saf. 2008 Jul; 17(7):751.
    View in: PubMed
    Score: 0.046
  16. Physical activity and mammographic density in a cohort of midlife women. Med Sci Sports Exerc. 2008 Mar; 40(3):451-6.
    View in: PubMed
    Score: 0.045
  17. Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361,859 recipients. Pharmacoepidemiol Drug Saf. 2008 Jan; 17(1):27-36.
    View in: PubMed
    Score: 0.045
  18. Menstrual and reproductive factors in relation to mammographic density: the Study of Women's Health Across the Nation (SWAN). Breast Cancer Res Treat. 2008 Nov; 112(1):165-74.
    View in: PubMed
    Score: 0.045
  19. A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients. Breast Cancer Res. 2006; 8(3):R25.
    View in: PubMed
    Score: 0.040
  20. Mammographic density and breast cancer after ductal carcinoma in situ. J Natl Cancer Inst. 2004 Oct 06; 96(19):1467-72.
    View in: PubMed
    Score: 0.036
  21. Mammographic density mediates the protective effect of early-life body size on breast cancer risk. Nat Commun. 2024 May 13; 15(1):4021.
    View in: PubMed
    Score: 0.035
  22. Daily aspirin use and prostate cancer risk in a large, multiracial cohort in the US. Cancer Causes Control. 2002 Jun; 13(5):427-34.
    View in: PubMed
    Score: 0.030
  23. CagA status of Helicobacter pylori infection and p53 gene mutations in gastric adenocarcinoma. Carcinogenesis. 2002 Mar; 23(3):419-24.
    View in: PubMed
    Score: 0.030
  24. Cross-cancer evaluation of polygenic risk scores for 16 cancer types in two large cohorts. Nat Commun. 2021 02 12; 12(1):970.
    View in: PubMed
    Score: 0.028
  25. Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts. Nat Commun. 2020 09 04; 11(1):4423.
    View in: PubMed
    Score: 0.027
  26. Body size, age at shaving initiation, and prostate cancer in a large, multiracial cohort. Prostate. 2000 May 01; 43(2):136-43.
    View in: PubMed
    Score: 0.026
  27. Alcohol and Tobacco Use in Relation to Mammographic Density in 23,456 Women. Cancer Epidemiol Biomarkers Prev. 2020 05; 29(5):1039-1048.
    View in: PubMed
    Score: 0.026
  28. Barbiturates, smoking, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev. 1998 Nov; 7(11):1049-50.
    View in: PubMed
    Score: 0.024
  29. Risk of recurrence after ductal carcinoma in situ of the breast. Cancer Epidemiol Biomarkers Prev. 1998 Aug; 7(8):689-96.
    View in: PubMed
    Score: 0.023
  30. Statin use and risk of multiple myeloma: An analysis from the cancer research network. Int J Cancer. 2017 08 01; 141(3):480-487.
    View in: PubMed
    Score: 0.021
  31. Risk of contralateral breast cancer among women with carcinoma in situ of the breast. Ann Surg. 1997 Jan; 225(1):69-75.
    View in: PubMed
    Score: 0.021
  32. Oral contraceptive use and risk of breast cancer in middle-aged women. Am J Epidemiol. 1996 Jul 15; 144(2):161-4.
    View in: PubMed
    Score: 0.020
  33. Exercise and Risk of Cardiovascular Events in Women With Nonmetastatic Breast Cancer. J Clin Oncol. 2016 08 10; 34(23):2743-9.
    View in: PubMed
    Score: 0.020
  34. Identification of Associations Between Prescribed Medications and Cancer: A Nationwide Screening Study. EBioMedicine. 2016 May; 7:73-9.
    View in: PubMed
    Score: 0.020
  35. A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk. Cancer Res. 2016 04 15; 76(8):2288-2300.
    View in: PubMed
    Score: 0.020
  36. Physical Activity and Risk of Male Breast Cancer. Cancer Epidemiol Biomarkers Prev. 2015 Dec; 24(12):1898-901.
    View in: PubMed
    Score: 0.019
  37. Prediagnostic Sex Steroid Hormones in Relation to Male Breast Cancer Risk. J Clin Oncol. 2015 Jun 20; 33(18):2041-50.
    View in: PubMed
    Score: 0.019
  38. Breastfeeding, PAM50 tumor subtype, and breast cancer prognosis and survival. J Natl Cancer Inst. 2015 Jul; 107(7).
    View in: PubMed
    Score: 0.019
  39. Imputation of the rare HOXB13 G84E mutation and cancer risk in a large population-based cohort. PLoS Genet. 2015 Jan; 11(1):e1004930.
    View in: PubMed
    Score: 0.018
  40. Tobacco and alcohol in relation to male breast cancer: an analysis of the male breast cancer pooling project consortium. Cancer Epidemiol Biomarkers Prev. 2015 Mar; 24(3):520-31.
    View in: PubMed
    Score: 0.018
  41. Race and breast cancer survival by intrinsic subtype based on PAM50 gene expression. Breast Cancer Res Treat. 2014 Apr; 144(3):689-99.
    View in: PubMed
    Score: 0.017
  42. Hormone receptors and breast cancer. Epidemiol Rev. 1993; 15(1):209-19.
    View in: PubMed
    Score: 0.016
  43. Smoking and survival after breast cancer diagnosis: a prospective observational study and systematic review. Breast Cancer Res Treat. 2012 Nov; 136(2):521-33.
    View in: PubMed
    Score: 0.016
  44. Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study. J Natl Cancer Inst. 2012 Sep 05; 104(17):1293-305.
    View in: PubMed
    Score: 0.016
  45. Ten-year risk of diagnostic mammograms and invasive breast procedures after breast-conserving surgery for DCIS. J Natl Cancer Inst. 2012 Apr 18; 104(8):614-21.
    View in: PubMed
    Score: 0.015
  46. Reproductive and menstrual factors and risk of ductal carcinoma in situ of the breast in a cohort of postmenopausal women. Cancer Causes Control. 2011 Oct; 22(10):1415-24.
    View in: PubMed
    Score: 0.014
  47. Multivitamin use and breast cancer outcomes in women with early-stage breast cancer: the Life After Cancer Epidemiology study. Breast Cancer Res Treat. 2011 Nov; 130(1):195-205.
    View in: PubMed
    Score: 0.014
  48. Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort. Breast Cancer Res Treat. 2011 Sep; 129(2):549-56.
    View in: PubMed
    Score: 0.014
  49. Serial glycosylated hemoglobin levels and risk of colorectal neoplasia among patients with type 2 diabetes mellitus. Cancer Epidemiol Biomarkers Prev. 2010 Dec; 19(12):3027-36.
    View in: PubMed
    Score: 0.014
  50. Lipophilic statin use and risk of breast cancer subtypes. Cancer Epidemiol Biomarkers Prev. 2010 Oct; 19(10):2479-87.
    View in: PubMed
    Score: 0.013
  51. Diabetes and cancer: a consensus report. Diabetes Care. 2010 Jul; 33(7):1674-85.
    View in: PubMed
    Score: 0.013
  52. Diabetes and cancer: a consensus report. CA Cancer J Clin. 2010 Jul-Aug; 60(4):207-21.
    View in: PubMed
    Score: 0.013
  53. Sex steroid metabolism polymorphisms and mammographic density in pre- and early perimenopausal women. Breast Cancer Res. 2009; 11(4):R51.
    View in: PubMed
    Score: 0.013
  54. Iron intake and body iron stores as risk factors for Barrett's esophagus: a community-based study. Am J Gastroenterol. 2008 Dec; 103(12):2997-3004.
    View in: PubMed
    Score: 0.012
  55. Hemochromatosis gene status as a risk factor for Barrett's esophagus. Dig Dis Sci. 2008 Dec; 53(12):3095-102.
    View in: PubMed
    Score: 0.011
  56. Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial. J Natl Cancer Inst. 2008 Apr 16; 100(8):563-71.
    View in: PubMed
    Score: 0.011
  57. Statin use and risk of prostate cancer in the California Men's Health Study cohort. Cancer Epidemiol Biomarkers Prev. 2007 Nov; 16(11):2218-25.
    View in: PubMed
    Score: 0.011
  58. The association between mammographic breast density and bone mineral density in the study of women's health across the nation. Ann Epidemiol. 2007 Aug; 17(8):575-83.
    View in: PubMed
    Score: 0.011
  59. Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology. 2007 Jul; 133(1):34-41; quiz 311.
    View in: PubMed
    Score: 0.011
  60. Barrett's esophagus and medications that relax the lower esophageal sphincter. Am J Gastroenterol. 2006 May; 101(5):937-44.
    View in: PubMed
    Score: 0.010
  61. The risk for malignant primary adult-onset glioma in a large, multiethnic, managed-care cohort: cigarette smoking and other lifestyle behaviors. J Neurooncol. 2004 May; 68(1):57-69.
    View in: PubMed
    Score: 0.009
  62. Risk factors for incident and recurrent condylomata acuminata among men. A population-based study. Sex Transm Dis. 1998 Jul; 25(6):278-84.
    View in: PubMed
    Score: 0.006
  63. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. JAMA. 1995 Jul 12; 274(2):137-42.
    View in: PubMed
    Score: 0.005
  64. Diet and genital warts: a case-control study. Sex Transm Dis. 1994 May-Jun; 21(3):149-54.
    View in: PubMed
    Score: 0.004

© 2024 Kaiser Permanente